Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Costentin

Showing results (201-210 of 244) with videos related to

Pageof 25
Sort By:
European Journal of Pharmacology|January 27, 1984
Involvement of endogenous enkephalins in the mouse 'behavioral despair' testL B Natan, P Chaillet, J M Lecomte, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphanB P Roques, E Lucas-Soroca, P Chaillet, et al.
Neuroscience Letters|July 17, 2009
Decreased responsiveness to low doses of apomorphine after dopamine agonists and the possible involvement of hyposensitivity of dopamine 'autoreceptors'M Baudry, J Costentin, H Marcais, et al.
British Journal of Pharmacology|April 1, 2000
The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptorsM El Yacoubi, C Ledent, J F Ménard, et al.
Life Sciences|January 1, 1983
Pain control by endogenous enkephalins is mediated by mu opioid receptorsP Chaillet, A Coulaud, M C Fournié-Zaluski, et al.
European Journal of Pharmacology|August 16, 1994
Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrierG Billaud, J F Menard, N Marcellin, et al.
Neuroscience Letters|October 11, 1996
A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in miceF M Van Kemmel, I Dubuc, E Bourdel, et al.
Physiology & Behavior|March 10, 2001
Divergent levels of anxiety in mice selected for differences in sensitivity to a convulsant agentC Suaudeau, D Rinaldi, E Lepicard, et al.
Life Sciences|June 18, 1979
Changes in dopamine receptors in mouse striatum following morphine treatmentsS de la Baume, G Patey, H Marçais, et al.
British Journal of Pharmacology|August 28, 2001
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout miceM El Yacoubi, C Ledent, M Parmentier, et al.
Pageof 25

Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
European Journal of Pharmacology|January 27, 1984
Involvement of endogenous enkephalins in the mouse 'behavioral despair' testL B Natan, P Chaillet, J M Lecomte, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphanB P Roques, E Lucas-Soroca, P Chaillet, et al.
Neuroscience Letters|July 17, 2009
Decreased responsiveness to low doses of apomorphine after dopamine agonists and the possible involvement of hyposensitivity of dopamine 'autoreceptors'M Baudry, J Costentin, H Marcais, et al.
British Journal of Pharmacology|April 1, 2000
The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptorsM El Yacoubi, C Ledent, J F Ménard, et al.
Life Sciences|January 1, 1983
Pain control by endogenous enkephalins is mediated by mu opioid receptorsP Chaillet, A Coulaud, M C Fournié-Zaluski, et al.
European Journal of Pharmacology|August 16, 1994
Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrierG Billaud, J F Menard, N Marcellin, et al.
Neuroscience Letters|October 11, 1996
A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in miceF M Van Kemmel, I Dubuc, E Bourdel, et al.
Physiology & Behavior|March 10, 2001
Divergent levels of anxiety in mice selected for differences in sensitivity to a convulsant agentC Suaudeau, D Rinaldi, E Lepicard, et al.
Life Sciences|June 18, 1979
Changes in dopamine receptors in mouse striatum following morphine treatmentsS de la Baume, G Patey, H Marçais, et al.
British Journal of Pharmacology|August 28, 2001
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout miceM El Yacoubi, C Ledent, M Parmentier, et al.
Pageof 25